134 related articles for article (PubMed ID: 11985350)
1. Betahistine inhibits food intake in rats.
Szelag A; Trocha M; Merwid-Lad A
Pol J Pharmacol; 2001; 53(6):701-7. PubMed ID: 11985350
[TBL] [Abstract][Full Text] [Related]
2. Effect of the H1-histamine receptor agonist betahistine on drinking and eating behavior in pygmy goats.
Rossi R; Del Prete E; Scharrer E
Physiol Behav; 1999 May; 66(3):517-21. PubMed ID: 10357443
[TBL] [Abstract][Full Text] [Related]
3. Histaminergic H3-Heteroreceptors as a Potential Mediator of Betahistine-Induced Increase in Cochlear Blood Flow.
Bertlich M; Ihler F; Freytag S; Weiss BG; Strupp M; Canis M
Audiol Neurootol; 2015; 20(5):283-93. PubMed ID: 26139562
[TBL] [Abstract][Full Text] [Related]
4. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
Gbahou F; Davenas E; Morisset S; Arrang JM
J Pharmacol Exp Ther; 2010 Sep; 334(3):945-54. PubMed ID: 20530654
[TBL] [Abstract][Full Text] [Related]
5. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
Malmlöf K; Zaragoza F; Golozoubova V; Refsgaard HH; Cremers T; Raun K; Wulff BS; Johansen PB; Westerink B; Rimvall K
Int J Obes (Lond); 2005 Dec; 29(12):1402-12. PubMed ID: 16151415
[TBL] [Abstract][Full Text] [Related]
6. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.
Poyurovsky M; Pashinian A; Levi A; Weizman R; Weizman A
Int Clin Psychopharmacol; 2005 Mar; 20(2):101-3. PubMed ID: 15729086
[TBL] [Abstract][Full Text] [Related]
7. The effect of betahistine on vestibular habituation: comparison of rotatory and sway habituation training.
Mierzwinski J; Kazmierczak H; Pawlak-Osinska K; Piziewicz A
Acta Otolaryngol; 2001 Jul; 121(5):610-5. PubMed ID: 11583395
[TBL] [Abstract][Full Text] [Related]
8. Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides.
Malmlöf K; Golozoubova V; Peschke B; Wulff BS; Refsgaard HH; Johansen PB; Cremers T; Rimvall K
Obesity (Silver Spring); 2006 Dec; 14(12):2154-62. PubMed ID: 17189541
[TBL] [Abstract][Full Text] [Related]
9. Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.
Pan JB; Yao BB; Miller TR; Kroeger PE; Bennani YL; Komater VA; Esbenshade TA; Hancock AA; Decker MW; Fox GB
Life Sci; 2006 Aug; 79(14):1366-79. PubMed ID: 16730751
[TBL] [Abstract][Full Text] [Related]
10. Effects of betahistine, a histamine H1 agonist and H3 antagonist, in a light/dark test in mice.
Imaizumi M; Miyazaki S; Onodera K
Methods Find Exp Clin Pharmacol; 1996; 18(1):19-24. PubMed ID: 8721252
[TBL] [Abstract][Full Text] [Related]
11. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
Dai H; Fu Q; Shen Y; Hu W; Zhang Z; Timmerman H; Leurs R; Chen Z
Eur J Pharmacol; 2007 Jun; 563(1-3):117-23. PubMed ID: 17350613
[TBL] [Abstract][Full Text] [Related]
12. Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat.
Tighilet B; Trottier S; Lacour M
Eur J Pharmacol; 2005 Oct; 523(1-3):54-63. PubMed ID: 16226741
[TBL] [Abstract][Full Text] [Related]
13. [The histamine H(3) receptor: a target for new drugs].
Arrang JM
Ann Pharm Fr; 2003 May; 61(3):173-84. PubMed ID: 12714930
[TBL] [Abstract][Full Text] [Related]
14. The vascular mechanism of action of betahistine in the inner ear of the guinea pig.
Laurikainen E; Miller JM; Nuttall AL; Quirk WS
Eur Arch Otorhinolaryngol; 1998; 255(3):119-23. PubMed ID: 9561856
[TBL] [Abstract][Full Text] [Related]
15. Histaminergic Pharmacology Modulates the Analgesic and Antiedematogenic Effects of Spinally Injected Morphine.
Stein T; Souza-Silva E; Mascarin L; Eto C; Fin FE; Tonussi CR
Anesth Analg; 2016 Jul; 123(1):238-43. PubMed ID: 27314696
[TBL] [Abstract][Full Text] [Related]
16. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.
Lian J; Huang XF; Pai N; Deng C
Psychoneuroendocrinology; 2014 Oct; 48():77-86. PubMed ID: 24992721
[TBL] [Abstract][Full Text] [Related]
17. Lack of substantial effect of the H(3)-antagonist thioperamide and of the non-selective mixed H(3)-antagonist/H(1)-agonist betahistine on amygdaloid kindled seizures.
Yoshida M; Noguchi E; Tsuru N
Epilepsy Res; 2000 Jul; 40(2-3):141-5. PubMed ID: 10863141
[TBL] [Abstract][Full Text] [Related]
18. Physiopathology of H3-receptors and pharmacology of betahistine.
Van Cauwenberge PB; De Moor SE
Acta Otolaryngol Suppl; 1997; 526():43-6. PubMed ID: 9107355
[TBL] [Abstract][Full Text] [Related]
19. H3 receptor antagonists/inverse agonists as anti-obesity agents.
Hancock AA
Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
[TBL] [Abstract][Full Text] [Related]
20. Betahistine, vestibular function and compensation: in vitro studies of vestibular function and plasticity.
Dutia MB
Acta Otolaryngol Suppl; 2000; 544():11-4. PubMed ID: 10904795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
